Patients with type 2 diabetes (T2D) at an elevated risk for kidney failure may stand to gain the most renal benefit with intensive glycemic control, but they also face the highest overall risk for ...

After the initiation of an AID system, glycemic control improved and the effect persisted throughout the study period. (HealthDay News) — Initiation of an automated insulin delivery (AID) system ...

Two-year data from Eli Lilly’s SURPASS-EARLY trial show reduced A1c, body weight, and cardiovascular risk factors.

Relaxed glycemic control targets were associated with an increased risk for skin, bone, and soft tissue infections among older adults with type 2 diabetes. Older adults with type 2 diabetes and ...

Carbohydrates have long carried a bad reputation in the world of diabetes management, but the science tells a more nuanced story. Not all carbs are created equal, and the right ones, chosen carefully ...

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without ...

Recent updates to the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) guidelines have focused on the need for more intensive therapy in patients with type 2 ...

52-week follow-up data from type 1 diabetes (“T1D”) patients in COVALENT-112 who completed ≥80% of protocol-specified dosing with the read-out expected in the second quarter of 2026. 26-week primary ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. On average, patients assigned to the diet lost 9.7 kg ...

In this episode, we are joined by Dr. Jordan Messler, Chief Medical Officer at Glytec, to discuss the Hospital Inpatient Quality-Reporting (IQR) Program and the two new glycemic management eCQMs on ...